Role of obesity, metabolic variables, and diabetes in HIV-associated neurocognitive disorder.
about
HIV-associated neurocognitive disorder--pathogenesis and prospects for treatmentSuccessful cognitive aging and health-related quality of life in younger and older adults infected with HIVHIV and aging: effects on the central nervous systemCerebral vasoreactivity is impaired in treated, virally suppressed HIV-infected individualsIdentifying risk factors for HIV-associated neurocognitive disorders using the international HIV dementia scale.Cerebrospinal fluid metabolomics reveals altered waste clearance and accelerated aging in HIV patients with neurocognitive impairment.HIV-associated neurocognitive disorder.Proteinuria is associated with neurocognitive impairment in antiretroviral therapy treated HIV-infected individualsThe synergistic effects of HIV, diabetes, and aging on cognition: implications for practice and researchDiabetes mellitus type 2 and abnormal glucose metabolism in the setting of human immunodeficiency virus.HIV-associated neurocognitive disorders: perspective on management strategiesBrain morphometric correlates of metabolic variables in HIV: the CHARTER study.Adiponectin and interleukin-6, but not adipose tissue, are associated with worse neurocognitive function in HIV-infected menHuman immunodeficiency virus (HIV) modulates the associations between insulin resistance and cognition in the current combination antiretroviral therapy (cART) era: a study of the Women's Interagency HIV Study (WIHS).Abdominal obesity contributes to neurocognitive impairment in HIV-infected patients with increased inflammation and immune activation.Diabetes and cognitive decline in a French cohort of patients infected with HIV-1.Rising Obesity Prevalence and Weight Gain Among Adults Starting Antiretroviral Therapy in the United States and CanadaCo-morbidities in persons infected with HIV: increased burden with older age and negative effects on health-related quality of life.Mixed membership trajectory models of cognitive impairment in the multicenter AIDS cohort studyThe Alzheimer's disease-8 and Montreal Cognitive Assessment as screening tools for neurocognitive impairment in HIV-infected persons.Preliminary Findings Describing Participant Experience With iSTEP, an mHealth Intervention to Increase Physical Activity and Improve Neurocognitive Function in People Living With HIV.Neurocognitive Function and Neuroimaging Markers in Virologically Suppressed HIV-positive Patients Randomized to Ritonavir-boosted Protease Inhibitor Monotherapy or Standard Combination ART: A Cross-sectional Substudy From the PIVOT Trial.Leptin, Adiponectin and Cognition in Middle-aged HIV-infected and Uninfected Women. The Brooklyn Women's Interagency HIV Study.Update on HIV-associated neurocognitive disorders.Physical exercise is associated with less neurocognitive impairment among HIV-infected adultsLipid Profiles and APOE4 Allele Impact Midlife Cognitive Decline in HIV-Infected Men on Antiretroviral Therapy.Changes in Insulin Resistance After Initiation of Raltegravir or Protease Inhibitors With Tenofovir-Emtricitabine: AIDS Clinical Trials Group A5260s.Poor Aerobic Fitness May Contribute to Cognitive Decline in HIV-infected Older Adults.Applications and limitations of inflammatory biomarkers for studies on neurocognitive impairment in HIV infection.Body mass index, inflammatory biomarkers and neurocognitive impairment in HIV-infected persons.Anthropometric measures and cognition in middle-aged HIV-infected and uninfected women. The Women's Interagency HIV Study.Cerebrospinal fluid cell-free mitochondrial DNA is associated with HIV replication, iron transport, and mild HIV-associated neurocognitive impairment.The burden of diabetes and hyperlipidemia in treated HIV infection and approaches for cardiometabolic care.Neurologic Complications and Considerations in HIV-Infected PersonsHIV associated neurocognitive disorders in the modern antiviral treatment era: prevalence, characteristics, biomarkers, and effects of treatment.HIV-associated neurocognitive disordersAn Overview of Human Immunodeficiency Virus Type 1-Associated Common Neurological Complications: Does Aging Pose a Challenge?Aging and Neurocognitive Functioning in HIV-Infected Women: a Review of the Literature Involving the Women's Interagency HIV Study.Utility of a brief computerized battery to assess HIV-associated neurocognitive impairment in a resource-limited setting.Treating HIV Infection in the Central Nervous System.
P2860
Q26766448-8BB07EC1-513B-44C1-A058-35CADE6E1E3DQ27000425-F29B4CCB-F921-49BB-B190-7E0BBAE633A1Q27025018-9B310732-9F02-48D9-B6C8-A5945F7BFB32Q30366554-4E37EEDB-6F2B-42A8-BAC8-26FFF32AA105Q33690579-3D5BB35E-A007-45A5-99A6-B8899B511F5CQ33863368-F22AD19B-3C2A-4F71-B69A-24442351C4D3Q33939729-B68B6A52-F571-453E-937C-636EF8A5BCB9Q34048920-8518682E-3AEF-4670-9CD4-DB8A7903CAEAQ34143299-DF995B2E-3484-4010-9849-2E0C0912CB8FQ34157971-C31EF9E1-FE80-4A7D-A2DB-F1AA0C82ADE2Q34652590-7B86B565-73E6-4119-85D2-2DA23DE9481AQ34716740-60065F02-77CA-4C3A-ACB1-AB5BA3013976Q35587294-FCDC0600-8614-48D1-AC92-EB024360BB87Q35880399-78291FF6-900B-4AD8-B0CB-7C8264714C9CQ36001196-4D198082-4234-42D6-ACCB-826E1F6EB82AQ36155683-26E58119-2FEE-4A77-81AE-720EB5144BEBQ36406918-D72AD4E9-5677-42EE-A854-5E43D4F8F73BQ36533831-7983784F-342A-41B5-9E0A-B9CA43C1F895Q36550686-D04117C3-9923-47B7-8691-A369F11D1E2BQ36849128-7C60F1EF-EB8F-46E7-B9C9-49DEF08FEFDDQ36995407-F5E8B638-968C-4631-84A0-BAE6CD878A4EQ37055030-1310481B-9760-435B-ADEB-CFCB2DBEF44BQ37173938-9EAE4BD0-D779-447D-960E-7C2611C48895Q37200962-9B97B73F-AA8E-429C-9612-678C6C184BDAQ37227851-90DDE68A-85EB-4B32-BF42-AFBC199D6078Q37284168-5F1B2019-36B0-4D81-9CBC-73C279266400Q37305570-DD3BE7CC-8948-463C-BF71-C2DC79FC4C9DQ37350363-56A7C410-9337-471A-BCE7-CD935107A3C9Q37467991-526ABAF4-276C-4AFE-B688-20353BF274DAQ37520967-FFC46419-778B-44DC-8F22-DA77886656BDQ37643066-8147A93B-1EFC-4A16-8474-238AB52523E3Q37731654-35BD16E9-7B76-448C-ACB4-91480E2AED6CQ38023235-95DF5EBA-BADC-4B3A-8195-A369AFBFFDAAQ38073190-8EE1F1CD-5CAD-47BA-864C-128EA7F4D225Q38223328-B53F400A-E537-4C4C-A339-D670E229DFCFQ38461834-8895F95B-6165-4E87-BA88-6B446600C3C1Q38628801-821B5ADE-0E34-4503-A877-B5AC845E1998Q38812539-3BCF9F59-D7B9-475C-BFD8-766DF12E3F09Q38854359-75DEEF60-ED58-4B45-B286-D7AB01BEBE8EQ39077816-13668851-5467-4EB2-AD9C-2E94B9B087A6
P2860
Role of obesity, metabolic variables, and diabetes in HIV-associated neurocognitive disorder.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Role of obesity, metabolic var ...... iated neurocognitive disorder.
@ast
Role of obesity, metabolic var ...... iated neurocognitive disorder.
@en
type
label
Role of obesity, metabolic var ...... iated neurocognitive disorder.
@ast
Role of obesity, metabolic var ...... iated neurocognitive disorder.
@en
prefLabel
Role of obesity, metabolic var ...... iated neurocognitive disorder.
@ast
Role of obesity, metabolic var ...... iated neurocognitive disorder.
@en
P2093
P2860
P1433
P1476
Role of obesity, metabolic var ...... iated neurocognitive disorder.
@en
P2093
C A Fitzsimons
J A Marquie-Beck
J A McCutchan
R K Heaton
S L Letendre
P2860
P304
P356
10.1212/WNL.0B013E3182478D64
P407
P577
2012-02-01T00:00:00Z